Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis

Clinical trial NCT00688545 · TERMINATED

Trial details

NCT number: NCT00688545
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Arthritis, Juvenile Rheumatoid

Start date: 2009-04-01
Primary completion: 2012-01-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.